• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Optimizing mCRC Therapy Sequencing: Key Considerations and Future Directions

Opinion
Video

Medical experts discuss additional factors for sequencing therapies such as FTD/TPI plus bevacizumab, fruquintinib, and regorafenib, and identify future research needs for optimizing therapy sequences.

Related Videos
4 experts are featured in this series
4 experts are featured in this series
Dr Vivek Subbiah
1 expert in this video
1 expert in this video
Dr Vivek Subbiah
Dr David Kuter
Dr Scott Soefje
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.